$SGMO Sangamo's ZFN has 8 clinical trials with 7 readouts. MC 1.5B and I believe grossly undervalued. Tech, like $BLT is elegant and nuanced, vastly superior to CRISPR. Deals are out there, SGMO will bolt on a smaller co, if we were lucky it would be us, alas we got PSS and NANT. We'll see. Data is king, but the mices are getting old and TT-034 may mark our high err low point? BLT remains a mystery to me.
BLT Price at posting:
17.0¢ Sentiment: Hold Disclosure: Held
